Methods and compositions for treating hot flashes

ABSTRACT

Hot flashes are treated by topical application of a treatment composition including an extract of a green marine algae. A preferred green marine algae is  enteromorpha compressa.

RELATED APPLICATIONS

This application is a continuation application of pending U.S. patentapplication Ser. No. 12/154,608 filed on May 22, 2008.

BACKGROUND OF THE INVENTION

This invention relates to methods for treating hot flashes. According toanother aspect, the invention pertains to compositions useful intreating hot flashes.

Hot flashes are mostly caused by the hormonal changes of menopause, butcan also be affected by lifestyle and medications. A diminished level ofestrogen has a direct effect on the hypothalamus, the part of the brainresponsible for controlling appetite, sleep cycles, sex hormones, andbody temperature. The drop in estrogen confuses the hypothalamus—whichis sometimes referred to as the body's “thermostat”—and makes it read“too hot.”

The brain responds to this report by broadcasting an alert to the heart,blood vessels, and nervous system to get rid of the heat. The message isinstantly transmitted by the nervous system's chemical messenger,epinephrine, and related compounds: norepinephrine, prostaglandin,serotonin. The heart pumps faster, the blood vessels dilate to circulatemore blood to radiate more heat, and the perspiration glands releaseperspiration to cool the body off even more.

This heat-releasing mechanism is how the body prevents overheating inthe summer. But, when the process is triggered instead by a drop inestrogen, the brain's confused response can make the person veryuncomfortable. Some women's skin temperature can rise 6° C. during a hotflash. The body cools down when it shouldn't and perspiration leaves theperson soaking wet.

Eighty-five percent of the women in the United States experience hotflashes of some kind as they approach menopause and for the first yearor two after their menstrual periods stop. Between 20 and 50% of womencontinue to have them for many more years. As time goes on, theintensity decreases.

There is considerable variation in time of onset, duration, frequency,and the nature of hot flashes. An episode can last a few seconds or afew minutes, occasionally even an hour, but it can take another halfhour for the person to feel well again. The most common time of onset isbetween six and eight in the morning, and between six to ten at night.

Most women have mild to moderate hot flashes, but about 10-15% of womenexperience such severe hot flashes that they seek medical attention. Thefaster the person goes through the transition from regular periods to noperiods—the peri-menopause or climacteric—the more significant the hotflashes will be.

Women experiencing hot flashes may encounter a variety of symptoms,including a feeling of mild warmth to intense heat spreading through theupper body and face, a flushed appearance with red, blotchy skin on theface, neck and upper chest, rapid heartbeat, perspiration (mostly on theupper body) and a chilled feeling as the hot flash subsides.

Aside from obvious techniques such as wearing light clothing, using afan, drinking cold drinks, controlled breathing, etc., the prior art hassuggested a number of non-prescription dietary supplements to curb hotflashes, such as black cohosh, soy, red clover, and vitamin E. However,none of these have proven effective in clinical trials.

Low doses of some anti-depressants have been shown to decrease hotflashes in some clinical trials, notably selective serotonin reuptakeinhibitors and norepinephrine reuptake inhibitors. There are potentialside effects from these medications, such as nausea, dizziness, weightgain and sexual dysfunction.

Other prescription medications have provided some relief from hotflashes, such as Gabapentin (Neurotinin) and Clonidine, but, again, sideeffects such as drowsiness, dizziness, nausea, imbalance, dry mouth andconstipation may limit use of the drugs.

Hormone therapies have proven most effective, such as estrogen therapyand progesterone therapy and combinations of estrogen and progesterone.However, there are definite risks to hormone therapy such as increasedrisk of breast cancer, stroke and heart disease.

Accordingly, it would be highly desirable to provide a treatment for hotflashes which is effective and which does not cause debilitating sideeffects. In particular, it would be desirable to provide such treatmentwhich can be used simultaneously with hormone therapy, allowing hormonetherapy at lower (safer) dose rate and lower (safer) total doses, whileproviding effective results.

SUMMARY OF THE INVENTION

I have now discovered a method of treating hot flashes of a woman duringperi-menopause or menopause, comprising applying to the skin of thewoman experiencing hot flash onset or hot flash symptoms a compositioncomprising an oligosaccharide extract of green marine algae, such asUvale (L) or enteromorpha (L), in a pharmacologically acceptable liquidcarrier.

In a preferred embodiment of the invention, the carrier includes waterand a humectant which is at least one member selected of the groupconsisting of glycerine and an alkylene glycol, e.g. propylene glycol orbutylene glycol. The quantities of these components will vary with theother components present and the solubilities of the other components,in accordance with art-recognized principles.

The amount of the oligosaccharide extract component varies from about0.5 to about 10 wt. % of the total composition. The preferred amount isabout 4 wt. % , but lower concentrations are at least partly operableand larger concentrations are not harmful.

DETAILED DESCRIPTION OF THE INVENTION

The composition is applied topically to the skin of the womanexperiencing hot flash onset or hot flash symptoms. The composition isliberally applied directly to the affected areas of skin, which mayinclude the upper body and face. Application can be made directly bypouring a quantity on the skin and then spreading it by hand to theaffected skin area or the composition can be applied by a sponge or padcarrying the composition. Alternatively, application can be effected byspraying the composition from a pressurized container through afinger-actuated spray nozzle. In the presently preferred embodiment, thecomposition is topically applied from a non-pressurized bottle equippedwith a finger-actuated pump. The pump delivers the composition in liquidform to a spray nozzle, which converts the liquid to an aerosol or sprayof fine droplets.

The liquid carrier of the composition is aqueous, but may includeglycerine and/or butylene glycol as humectants and as co-solvents forthe other components of the composition, some of which are water solubleand some of which may be soluble in non-polar solvents. Additionally,glycerine improves the texture and viscosity of the composition afterapplication, providing for even spreading and preventing it from runningoff the area of skin intended for application.

The green marine algae component of the compositions used in practicingthe invention is an extract. Preparation of the extract can beaccomplished by a wide variety of techniques which will readily occur tothose skilled in the art.

For example, the algae is first washed and blotted dry between sheets ofabsorbent paper. The dried algae is then crushed in a mortar and pestlewith acid-washed sand in the presence of a phosphate buffer salineextractant (0.005 M phosphate and 0. 15 M NaCl, pH=7.4). The resultantcrushed algae-sand mixture is centrifuged (Remi R-10) at 10,000 rpm forfifteen minutes at 4° C. The pellet remaining in the centrifuge cup isdiscarded and the supernatant is then diluted with the phosphate bufferto make a 20 wt. % extract.

Alternatively, the algae is heated in a hot air current and ground to aflour in a Waring blender. The flour is then extracted in a Soxhletapparatus with acetone (48 hours) and ethanol (48 hours) to remove thepigmentation. The depigmented flour is than sequentially extracted withammonium oxylate in a sodium acetate buffer (pH=5). The unextractedresidue is separated from the liquid using a centrifuge, followed byfiltering the centrifugate through a G-3 fritted glass filter. Thefiltered centrifugate is washed with aqueous ethanol, ethanol andacetone and vacuum dried over P₂O₅, to yield a powdered oxylate-solubleextract.

Similar procedures or other standard procedures in the art are employedto provide extracts of other botanicals which may be included incompositions used in accordance with the presently preferred practice ofthe method of the invention. For example, it may be desirable to includeone or more botanical extracts in the compositions used in accordancewith the invention. If so, suggested ranges for these extracts are fromabout 0.0001 to 10%, preferably about 0.0005 to 8%, more preferablyabout 0.01 to 0.05% by weight of the total composition.

Suitable botanical extracts include extracts from plants (herbs, roots,flowers, fruits, seeds) such as flowers, fruits, vegetables, includingacacia (dealbata, farnesiana, senegal), acer saccharinum (sugar maple),acidopholus, acorus, aesculus, agaricus, agave, agrimonia, aloe, citrus,brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear,lemon, lime, pea, seaweed, green tea, chamomile, willowbark, mulberry,poppy, and those set forth on pages 1646 through 1660 of the CTFACosmetic Ingredient Handbook, Eighth Edition, Volume 2. Further specificexamples include, but are not limited to, Glycyrrhiza Glabra, SalixNigra, Macrocycstis Pyrifera, Pyrus Malus, Saxifraga Sarmentosa, VitisVinifera, Morus Nigra, Scutellaria Baicalensis, Anthemis Nobilis, SalviaSclarea, Rosmarinus Officianalis, Citrus Medica Limonum, and mixturesthereof. In the presently preferred embodiment of the invention thetopically composition includes extracts of grapefruit, cucumber, greentea, bee pollen, orange flower, chamomile, sea kelp and lavender.

The following examples are provided in order to illustrate practice ofthe invention and to identify the presently preferred embodimentsthereof. These examples are only illustrative and are not to be taken asa limitation on the scope of the invention, which is defined only by theappended claims.

The following compositions are formulated. All numbers indicate percentby weight:

EXAMPLE 1

purified water 77.7 glycerine 11.1 butylene glycol 11.1

EXAMPLE 2

purified water 70.0 glycerine 10.0 butylene glycol 10.0 enteromorphacompressa extract 10.0

EXAMPLE 3

Skin temperatures are measured one, five and ten minutes afterapplication by spray from a finger-actuated spray pump container of thecompositions of Examples 1 and 2, to the forearms, foreheads, throatsand necks of women who are experiencing hot flashes. The skintemperatures of the test subjects are measured at the forehead. Thereductions in skin temperatures from the initial temperature are:

Treatment Reduction In Skin Temperature at Minutes (° F.) Composition 15 10 Example 1 1.0 0.5 0 Example 2 2.0 3.0 3.0

EXAMPLE 4

The following formulation is prepared to illustrate the composition usedin accordance with the presently preferred practice of the method of theinvention:

% by Weight Purified Water 91.24 Glycerine 2.00 Butylene Glycol 2.00enteromorpha compressa extract 4.00 Diazolidinyl urea/Iodopropynyl butyl0.40 carbamate (preservative) Polysorbate 80 0.30 (nonionic surfactant)Fragrance 0.05 Botanical extracts 0.01 Grapefruit extract Cucumberextract Green Tea extract Bee Pollen extract Citrus Flower extractChamomile extract Sea Kelp extract Lavender extract

EXAMPLE 5

Similar results are obtained if procedures of Examples 1-4 are repeated,except that the green marine algae component of the compositions areextracts of:

Enteromorpha adriatica

Enteromorpha ahlneriana var. roscoffensis

Enteromorpha aragoensis

Enteromorpha bayonnensis

Enteromorpha bulbosa

Enteromorpha chartacea f. minor

Enteromorpha compressa var. caespitosa

Enteromorpha compressa var. abbreviata

Enteromorpha adriatica

Enteromorpha ahlneriana var. roscoffensis

Enteromorpha aragoensis

Enteromorpha bayonnensis

Enteromorpha chartacea f. minor

Enteromorpha compressa f. gracillis

Enteromorpha intestinales

Enteromorpha clathera

Enteromorpha complanata

Enteromorpha vulgaris

Enteromorpha usneoides

Entermorpha chlorotica

Ulva compressa

Ulva confervoides

Ulva conglobata f. densa

Ulva cornuta

Ulva covelongensis

Ulva crassa

Ulva crassimembrana

Ulva curvata

Ulva dactylifera

Ulva rigida

Ulva rotundata

Codium fragile

1. A method of treating hot flashes of a woman during peri-menopause ormenopause, comprising applying to the skin of the woman experiencing hotflash onset or hot flash symptoms a composition comprising an extract ofa green marine algae in a pharmacologically acceptable liquid carrier.